Bristol-Myers Squibb Company (BMY)
USD 56.84
(-1.41%)
USD 56.84
(-1.41%)
| Year | Gross Profit | Gross Profit Growth |
|---|---|---|
| 2023 | 34.31 Billion USD | -4.74% |
| 2022 | 36.02 Billion USD | -1.16% |
| 2021 | 36.44 Billion USD | 18.54% |
| 2020 | 30.74 Billion USD | 70.17% |
| 2019 | 18.06 Billion USD | 12.82% |
| 2018 | 16.01 Billion USD | 8.86% |
| 2017 | 14.71 Billion USD | 1.58% |
| 2016 | 14.48 Billion USD | 14.47% |
| 2015 | 12.65 Billion USD | 5.89% |
| 2014 | 11.94 Billion USD | 1.54% |
| 2013 | 11.76 Billion USD | -9.57% |
| 2012 | 13.01 Billion USD | -16.84% |
| 2011 | 15.64 Billion USD | 10.13% |
| 2010 | 14.2 Billion USD | 3.94% |
| 2009 | 13.66 Billion USD | -3.75% |
| 2008 | 14.2 Billion USD | 8.16% |
| 2007 | 13.13 Billion USD | 9.8% |
| 2006 | 11.95 Billion USD | -9.95% |
| 2005 | 13.27 Billion USD | -0.84% |
| 2004 | 13.39 Billion USD | 0.67% |
| 2003 | 13.3 Billion USD | 13.39% |
| 2002 | 11.73 Billion USD | -15.29% |
| 2001 | 13.84 Billion USD | -2.5% |
| 2000 | 14.2 Billion USD | -7.54% |
| 1999 | 15.36 Billion USD | 9.31% |
| 1998 | 14.05 Billion USD | 9.55% |
| 1997 | 12.82 Billion USD | 10.41% |
| 1996 | 11.61 Billion USD | 9.84% |
| 1995 | 10.57 Billion USD | 15.1% |
| 1994 | 9.19 Billion USD | 5.73% |
| 1993 | 8.69 Billion USD | 1.14% |
| 1992 | 8.59 Billion USD | 1.4% |
| 1991 | 8.47 Billion USD | 10.5% |
| 1990 | 7.67 Billion USD | 13.98% |
| 1989 | 6.72 Billion USD | 7.51% |
| Year | Gross Profit | Gross Profit Growth |
|---|---|---|
| 2024 Q2 | 6.8 Billion USD | -23.87% |
| 2024 Q3 | 8.93 Billion USD | 31.38% |
| 2024 Q1 | 8.93 Billion USD | 2.3% |
| 2023 Q4 | 8.73 Billion USD | 3.22% |
| 2023 Q3 | 8.46 Billion USD | 1.32% |
| 2023 Q2 | 8.35 Billion USD | -4.8% |
| 2023 FY | 34.31 Billion USD | -4.74% |
| 2023 Q1 | 8.77 Billion USD | -0.48% |
| 2022 Q4 | 8.81 Billion USD | -0.59% |
| 2022 Q1 | 9.17 Billion USD | -4.69% |
| 2022 Q2 | 9.16 Billion USD | -0.11% |
| 2022 FY | 36.02 Billion USD | -1.16% |
| 2022 Q3 | 8.86 Billion USD | -3.29% |
| 2021 Q1 | 8.23 Billion USD | 0.91% |
| 2021 FY | 36.44 Billion USD | 18.54% |
| 2021 Q2 | 9.25 Billion USD | 12.38% |
| 2021 Q3 | 9.33 Billion USD | 0.89% |
| 2021 Q4 | 9.62 Billion USD | 3.17% |
| 2020 Q3 | 8.03 Billion USD | 8.18% |
| 2020 Q1 | 7.11 Billion USD | 30.55% |
| 2020 Q2 | 7.43 Billion USD | 4.37% |
| 2020 FY | 30.74 Billion USD | 70.17% |
| 2020 Q4 | 8.15 Billion USD | 1.49% |
| 2019 Q4 | 5.45 Billion USD | 29.93% |
| 2019 Q3 | 4.19 Billion USD | -1.96% |
| 2019 Q2 | 4.28 Billion USD | 5.03% |
| 2019 Q1 | 4.07 Billion USD | -4.83% |
| 2019 FY | 18.06 Billion USD | 12.82% |
| 2018 Q4 | 4.28 Billion USD | 5.94% |
| 2018 Q1 | 3.6 Billion USD | -4.42% |
| 2018 Q2 | 4.07 Billion USD | 13.02% |
| 2018 FY | 16.01 Billion USD | 8.86% |
| 2018 Q3 | 4.04 Billion USD | -0.88% |
| 2017 Q4 | 3.77 Billion USD | 2.55% |
| 2017 FY | 14.71 Billion USD | 1.58% |
| 2017 Q3 | 3.68 Billion USD | 2.79% |
| 2017 Q2 | 3.58 Billion USD | -2.4% |
| 2017 Q1 | 3.67 Billion USD | -4.92% |
| 2016 FY | 14.48 Billion USD | 14.47% |
| 2016 Q4 | 3.86 Billion USD | 6.72% |
| 2016 Q2 | 3.66 Billion USD | 9.76% |
| 2016 Q3 | 3.61 Billion USD | -1.31% |
| 2016 Q1 | 3.33 Billion USD | 0.12% |
| 2015 Q2 | 3.15 Billion USD | -1.38% |
| 2015 Q4 | 3.33 Billion USD | 12.21% |
| 2015 Q3 | 2.97 Billion USD | -5.65% |
| 2015 FY | 12.65 Billion USD | 5.89% |
| 2015 Q1 | 3.19 Billion USD | -2.98% |
| 2014 FY | 11.94 Billion USD | 1.54% |
| 2014 Q3 | 2.91 Billion USD | 0.55% |
| 2014 Q2 | 2.89 Billion USD | 1.93% |
| 2014 Q1 | 2.84 Billion USD | -10.26% |
| 2014 Q4 | 3.29 Billion USD | 12.97% |
| 2013 FY | 11.76 Billion USD | -9.57% |
| 2013 Q4 | 3.16 Billion USD | 9.62% |
| 2013 Q3 | 2.89 Billion USD | -1.7% |
| 2013 Q2 | 2.94 Billion USD | 6.21% |
| 2013 Q1 | 2.76 Billion USD | -11.17% |
| 2012 Q1 | 3.94 Billion USD | -3.4% |
| 2012 Q3 | 2.74 Billion USD | -14.04% |
| 2012 Q2 | 3.19 Billion USD | -19.0% |
| 2012 FY | 13.01 Billion USD | -16.84% |
| 2012 Q4 | 3.11 Billion USD | 13.35% |
| 2011 FY | 15.64 Billion USD | 10.13% |
| 2011 Q1 | 3.66 Billion USD | -0.78% |
| 2011 Q2 | 3.95 Billion USD | 7.77% |
| 2011 Q3 | 3.93 Billion USD | -0.38% |
| 2011 Q4 | 4.08 Billion USD | 3.78% |
| 2010 Q1 | 3.5 Billion USD | 57.84% |
| 2010 Q3 | 3.51 Billion USD | 0.77% |
| 2010 Q4 | 3.69 Billion USD | 5.09% |
| 2010 FY | 14.2 Billion USD | 3.94% |
| 2010 Q2 | 3.49 Billion USD | -0.29% |
| 2009 Q1 | 3.6 Billion USD | -3.35% |
| 2009 Q2 | 3.92 Billion USD | 8.91% |
| 2009 FY | 13.66 Billion USD | -3.75% |
| 2009 Q3 | 3.92 Billion USD | 0.05% |
| 2009 Q4 | 2.21 Billion USD | -43.49% |
| 2008 Q4 | 3.72 Billion USD | 2.96% |
| 2008 Q1 | 3.52 Billion USD | 8.8% |
| 2008 Q2 | 3.53 Billion USD | 0.26% |
| 2008 FY | 14.2 Billion USD | 8.16% |
| 2008 Q3 | 3.62 Billion USD | 2.46% |
| 2007 Q3 | 3.42 Billion USD | 1.45% |
| 2007 Q1 | 3.08 Billion USD | 11.5% |
| 2007 FY | 13.13 Billion USD | 9.8% |
| 2007 Q4 | 3.23 Billion USD | -5.51% |
| 2007 Q2 | 3.37 Billion USD | 9.57% |
| 2006 Q2 | 3.3 Billion USD | 3.22% |
| 2006 FY | 11.95 Billion USD | -9.95% |
| 2006 Q1 | 3.2 Billion USD | -6.54% |
| 2006 Q4 | 2.76 Billion USD | 2.86% |
| 2006 Q3 | 2.68 Billion USD | -18.59% |
| 2005 FY | 13.27 Billion USD | -0.84% |
| 2005 Q2 | 3.4 Billion USD | 7.61% |
| 2005 Q4 | 3.42 Billion USD | 4.26% |
| 2005 Q3 | 3.28 Billion USD | -3.58% |
| 2005 Q1 | 3.16 Billion USD | -8.18% |
| 2004 Q1 | 3.28 Billion USD | -8.6% |
| 2004 FY | 13.39 Billion USD | 0.67% |
| 2004 Q3 | 3.32 Billion USD | -0.24% |
| 2004 Q4 | 3.44 Billion USD | 3.61% |
| 2004 Q2 | 3.33 Billion USD | 1.61% |
| 2003 Q2 | 3.25 Billion USD | 7.6% |
| 2003 Q3 | 3.42 Billion USD | 5.31% |
| 2003 FY | 13.3 Billion USD | 13.39% |
| 2003 Q4 | 3.59 Billion USD | 4.72% |
| 2003 Q1 | 3.02 Billion USD | -0.07% |
| 2002 FY | 11.73 Billion USD | -15.29% |
| 2002 Q1 | 2.69 Billion USD | -26.64% |
| 2002 Q2 | 2.65 Billion USD | -1.26% |
| 2002 Q3 | 2.88 Billion USD | 8.51% |
| 2002 Q4 | 3.02 Billion USD | 5.03% |
| 2001 FY | 13.84 Billion USD | -2.5% |
| 2001 Q1 | 3.4 Billion USD | -7.5% |
| 2001 Q2 | 3.36 Billion USD | -1.29% |
| 2001 Q3 | 3.41 Billion USD | 1.49% |
| 2001 Q4 | 3.66 Billion USD | 7.5% |
| 2000 Q2 | 4.07 Billion USD | 0.17% |
| 2000 Q3 | 3.55 Billion USD | -12.88% |
| 2000 Q4 | 3.68 Billion USD | 3.72% |
| 2000 Q1 | 4.06 Billion USD | -1.41% |
| 2000 FY | 14.2 Billion USD | -7.54% |
| 1999 Q2 | 3.72 Billion USD | 0.19% |
| 1999 FY | 15.36 Billion USD | 9.31% |
| 1999 Q4 | 4.12 Billion USD | 8.69% |
| 1999 Q1 | 3.71 Billion USD | -0.8% |
| 1999 Q3 | 3.79 Billion USD | 1.96% |
| 1998 Q3 | 3.48 Billion USD | 3.5% |
| 1998 Q2 | 3.37 Billion USD | -2.29% |
| 1998 FY | 14.05 Billion USD | 9.55% |
| 1998 Q4 | 3.74 Billion USD | 7.4% |
| 1998 Q1 | 3.44 Billion USD | 0.15% |
| 1997 Q4 | 3.44 Billion USD | 8.27% |
| 1997 FY | 12.82 Billion USD | 10.41% |
| 1997 Q1 | 3.1 Billion USD | 2.41% |
| 1997 Q2 | 3.1 Billion USD | 0.03% |
| 1997 Q3 | 3.18 Billion USD | 2.55% |
| 1996 FY | 11.61 Billion USD | 9.84% |
| 1996 Q4 | 3.02 Billion USD | 5.58% |
| 1996 Q3 | 2.86 Billion USD | 0.39% |
| 1996 Q2 | 2.85 Billion USD | -0.28% |
| 1996 Q1 | 2.86 Billion USD | -0.38% |
| 1995 Q4 | 2.87 Billion USD | 11.91% |
| 1995 Q3 | 2.57 Billion USD | -1.98% |
| 1995 Q2 | 2.62 Billion USD | 4.46% |
| 1995 Q1 | 2.51 Billion USD | 2.12% |
| 1995 FY | 10.57 Billion USD | 15.1% |
| 1994 Q1 | 2.16 Billion USD | -4.15% |
| 1994 Q4 | 2.45 Billion USD | 9.05% |
| 1994 Q3 | 2.25 Billion USD | -2.34% |
| 1994 Q2 | 2.3 Billion USD | 6.41% |
| 1994 FY | 9.19 Billion USD | 5.73% |
| 1993 Q4 | 2.26 Billion USD | 4.05% |
| 1993 FY | 8.69 Billion USD | 1.14% |
| 1993 Q1 | 2.09 Billion USD | 10.47% |
| 1993 Q2 | 2.16 Billion USD | 3.49% |
| 1993 Q3 | 2.17 Billion USD | 0.55% |
| 1992 Q4 | 1.89 Billion USD | -19.66% |
| 1992 Q2 | 2.2 Billion USD | 2.75% |
| 1992 Q1 | 2.14 Billion USD | -3.81% |
| 1992 FY | 8.59 Billion USD | 1.4% |
| 1992 Q3 | 2.35 Billion USD | 6.9% |
| 1991 Q3 | 2.1 Billion USD | 1.88% |
| 1991 FY | 8.47 Billion USD | 10.5% |
| 1991 Q4 | 2.22 Billion USD | 5.69% |
| 1991 Q2 | 2.07 Billion USD | 0.15% |
| 1991 Q1 | 2.06 Billion USD | 1.32% |
| 1990 Q4 | 2.04 Billion USD | 3.98% |
| 1990 FY | 7.67 Billion USD | 13.98% |
| 1990 Q2 | 1.84 Billion USD | 1.54% |
| 1990 Q1 | 1.82 Billion USD | -22.88% |
| 1990 Q3 | 1.96 Billion USD | 6.17% |
| 1989 Q4 | 2.36 Billion USD | 1.72% |
| 1989 Q2 | 2.24 Billion USD | -0.93% |
| 1989 Q1 | 2.26 Billion USD | 5.64% |
| 1989 Q3 | 2.32 Billion USD | 3.39% |
| 1989 FY | 6.72 Billion USD | 7.51% |
| Name | Gross Profit | Gross Profit Difference |
|---|---|---|
| AbbVie Inc. | 45.53 Billion USD | 24.65% |
| Bristol-Myers Squibb Company Ce | 34.31 Billion USD | 0.0% |
| Johnson & Johnson | 58.6 Billion USD | 41.451% |
| Eli Lilly and Company | 27.04 Billion USD | -26.888% |
| Merck & Co., Inc. | 43.98 Billion USD | 21.996% |
| Novartis AG | 34.18 Billion USD | -0.366% |
| Organon & Co. | 3.74 Billion USD | -815.502% |
| Pfizer Inc. | 28.8 Billion USD | -19.105% |